Search results for: 'dbco peg4 vc pab dmea pnu 159682 ba2671'
-
B7007 PNU 282987Summary: α7 nAChR agonist -
B7166 PNU 96415ESummary: dopamine D4 and serotonergic 5-HT2A receptor antagonist -
B7422 PNU 74654Summary: Wnt signaling pathway inhibitor -
B6906 PNU 142633Summary: 5-HT1D receptor agonist -
B7381 PNU 177864 hydrochlorideSummary: dopamine D3 receptor antagonist -
B6973 PNU 22394 hydrochlorideSummary: 5-HT2C agonist and partial 5-HT2A/5-HT2B agonist -
B6948 PNU 37883 hydrochlorideSummary: Kir6 (KATP) channel antagonist -
BA2645 Mal-PEG4-VC-PAB-DMEA-PNU-159682Summary: Mal-PEG4-VC-PAB-DMEA-PNU-159682 is an active molecule-coupling consisting of the ADC connector Mal-PEG4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682. -
BA2630 DBCO-PEG4-VC-PAB-MMAESummary: DBCO-PEG4-VC-PAB-MMAE consists of (DBCO-PEG4-VC-PAB) and the microtubule protein polymerization inhibitor MMAE. -
BA2647 DBCO-PEG4-Val-Cit-PAB-MMAFSummary: DBCO-PEG4-Val-Cit-PAB-MMAF consists of degradable (cleavable) 4-unit PEG-containing (DBCO-PEG4-Val-Cit-PAB) and MMAF.

